COPD epidemiology

Ioannides, A. E., Morgan, A. D., & Quint, J. K. (2024). Patient pathways for four major chronic respiratory diseases in England between 2008 and 2021. BMJ Open Respir Res, 11. http://doi.org/10.1136/bmjresp-2023-002273
Amegadzie, J. E., Gao, Z. ., Quint, J. K., Russell, R. ., Hurst, J. R., . Y. Lee, T. ., … Sadatsafavi, M. . (2023). QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax. http://doi.org/10.1136/thorax-2023-220615
Whittaker, H. ., Rothnie, K. J., & Quint, J. K. (2023). Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax. http://doi.org/10.1136/thorax-2022-219320
Lenoir, A. ., Whittaker, H. ., Gayle, A. ., Jarvis, D. ., & Quint, J. K. (2022). Mortality in non-exacerbating COPD: a longitudinal analysis of UK primary care data. Thorax. http://doi.org/10.1136/thorax-2022-218724
Whittaker, H. ., Nordon, C. ., Rubino, A. ., Morris, T. ., Xu, Y. ., de Nigris, E. ., … Quint, J. K. (2022). Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax. http://doi.org/10.1136/thorax-2022-219039
Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. BMJ Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243
Whittaker, H. ., Van Ganse, E. ., Dalon, F. ., Nolin, M. ., Marrant-Micallef, C. ., Pison, C. ., … Belhassen, M. . (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. BMJ Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2021-001150